BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2017 12:33:29 AM | Browse: 852 | Download: 1076
Publication Name World Journal of Gastroenterology
Manuscript ID 33109
Country/Territory Italy
Received
2017-02-06 16:09
Peer-Review Started
2017-02-09 09:24
To Make the First Decision
2017-03-03 09:15
Return for Revision
2017-03-03 11:09
Revised
2017-03-15 04:02
Second Decision
2017-03-28 16:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-03-31 08:04
Articles in Press
2017-03-31 08:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-04-17 09:28
Publish the Manuscript Online
2017-05-27 00:33
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Hepatitis C in injection drug users: It is time to treat
Manuscript Source Invited Manuscript
All Author List Alberto Grassi and Giorgio Ballardini
Funding Agency and Grant Number
Corresponding Author Alberto Grassi, MD, PhD, Internal Medicine and Hepatology Division, Infermi Hospital, Viale Settembrini 2, 47921 Rimini, Italy. albgrassi@yahoo.com
Key Words Hepatitis C; Drug users; Peg-interferon; Direct antiviral agents; Hepatitis C virus treatment
Core Tip It is well demonstrated that injection drug users (IDUs) on maintenance treatment with methadone/buprenorphine can be treated for hepatitis C virus (HCV) with response rate, tolerability and side effects similar to those reported in non-IDUs. European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C 2016 confirm that HCV treatment for IDUs should be considered on an individualized basis and delivered within a multidisciplinary team setting; a history of intravenous drug use and recent drug use at treatment initiation are not associated with reduced sustained viral response and decisions to treat must be made on a case-by-case basis.
Publish Date 2017-05-27 00:33
Citation Grassi A, Ballardini G. Hepatitis C in injection drug users: It is time to treat. World J Gastroenterol 2017; 23(20): 3569-3571
URL http://www.wjgnet.com/1007-9327/full/v23/i20/3569.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i20.3569
Full Article (PDF) WJG-23-3569.pdf
Full Article (Word) WJG-23-3569.doc
Manuscript File 33109-Review.doc
Answering Reviewers 33109-Answering reviewers.pdf
Audio Core Tip 33109-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 33109-Conflict-of-interest statement.pdf
Copyright License Agreement 33109-Copyright assignment.pdf
Peer-review Report 33109-Peer-review(s).pdf
Scientific Misconduct Check 33109-Scientific misconduct check.pdf
Scientific Editor Work List 33109-Scientific editor work list.pdf